FZ-AD004

· Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FZ-AD004, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FZ-AD004 in Patients With Advanced Solid Tumors [Phase 1]